Merck's antiviral pill cut the risk of hospitalization or death by roughly half in a late-stage trial, and could become a powerful tool in reining in the pandemic.
Merck cheered investors and healthcare experts alike on Friday with the news that its COVID-19 antiviral cut the risk of hospitalization or death by roughly half in a late-stage trial, and could become a powerful tool in reining in the pandemic.
Molnupiravir is a pill administered orally in capsule form every 12 hours for five days, according to clinicaltrials.gov.Through Day 29 in the Phase 3 trial, no patients given molnupiravir died, compared with the eight patients who died on the placebo. The company is now planning to submit an application for emergency-use authorization for the treatment from the Food and Drug Administration and to seek authorizations from other regulatory bodies around the world.
iframe.twitter-tweet { width: 100% !important; } iframe.twitter-tweet { width: 100% !important; } The news comes as the U.S. is averaging just under 2,000 COVID deaths a day, according to a New York Times tracker, a small improvement on the recent trend. Hospitalizations and new cases have been coming down, but the daily death rate had remained at more than 2,000 for the past few weeks.
Hospital staff, universally hailed as heroes in 2020 with nightly ovations raining down from windows and balconies, are now coming under threat from hostility, threats and violence from patients, who have become increasingly angry over safety rules aimed at stopping the spread of the virus, the Associated Press reported.
Coronavirus Update: BioNTech co-founder says COVID-19 will become manageable but may persist for several years Finland will start vaccinating minks on fur farms against COVID with an experimental vaccine, NDTV.com reported. Minks have been found to be susceptible to contracting the illness and to pass it on to humans. Last year, Denmark culled its entire mink population as a cautionary measure.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Merck Pill Intended to Be Covid-19’s Tamiflu Succeeds in Key StudyMerck said its experimental pill helped prevent serious illness and death in high-risk people infected with Covid-19, a step toward the virus’s first at-home treatment
Consulte Mais informação »
Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sectorPositive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies.
Consulte Mais informação »
COVID-19 live updates: US death toll set to surpass 700,000American Airlines told employees that all U.S.-based employees and certain international crew members must be vaccinated in light of the federal vaccine mandate.
Consulte Mais informação »
Australia to End Travel Ban in Pivot to Living With Covid-19Australia plans to end its travel ban for vaccinated citizens and permanent residents as the country pivots to living with Covid-19
Consulte Mais informação »
Pill Intended to Be Covid-19’s Tamiflu Succeeds in Key StudyMerck said its experimental pill helped prevent serious illness and death in high-risk people infected with Covid-19, a step toward the virus’s first at-home treatment
Consulte Mais informação »
NBA draws line as stars like Kyrie Irving, Andrew Wiggins balk at Covid vaccineThe NBA cannot force players to get vaccinated — any such mandate would require agreement between the league and the Players Association. But the league has flexed its muscle in another fashion, taking aim at the vaccine resisters’ bank accounts.
Consulte Mais informação »